ApoA-I production enhancer reduces inflammatory biomarkers in CAD and may affect HDL functionality Sep. 14, 2011
Portola's recombinant factor Xa inhibitor antidote reverses rivaroxaban effects in vivo Sep. 14, 2011
New biomarker to predict clinical outcome of sorafenib-treated hepatocellular carcinoma Sep. 12, 2011
RSS